Stocks
Deciphera Pharmaceuticals (DCPH) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.92 | 1.97 | 0.85 | 1.62 | 1.34 | 1.21 | |||
| Changes by years, y/y, % | +4% | -33% | -57% | +90% | -17% | -13.8% | |||
Deciphera Pharmaceuticals. Debt/EBITDA
Deciphera Pharmaceuticals. Debt/EBITDA, changes, %
Deciphera Pharmaceuticals (DCPH) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 1.97 | 1.53 | 1.51 | 1.34 | 1.21 | 1.21 | ||
| Changes by years, y/y, % | +147% | +11% | +0% | -18% | -39% | |||
| Changes by quarters, q/q, % | +21% | -22% | -1% | -12% | -9% | |||
